BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 26/07/2011

FDA Classifies Repetitive Transcranial Magnetic Stimulation System as Class II Device

The US Food and Drug Administration has classified the repetitive transcranial magnetic stimulation (rTMS) system as a Class II device, requiring special controls to ensure the device's safety and effectiveness.

Source: Federal Register — Health and Human ServicesOpen original release →